Prepared by: Dante Fichera, CPA
This reporting period companies based in California operating in the Biotechnology industry and that have raised their Series A round of financing led the pack in the amount of venture financing raised. Also, there was two IPOs this reporting period.
New to CapitalHunter.com, submit your business plan for a free review by our experienced staff of analysts and see if you qualify for investment capital. Also, if you would like to access our database of investors and newly financed companies please visit our website and receive a 10% discount by using the discount code $$$. Also, if you want to advertise with our newsletter (circulation 20,000) call us at 619-236-9998.
|
 |
CapitalHunter.com was able to verify that $562 million of venture capital was invested in 35 U.S.-based companies during this week’s reporting period. The average deal size was approximately 16.06 million. The amount of venture capital invested this period increased by 65% compared to last periods $341 million. |
|
|
 |
Geographically, 17 California companies raised $330.3 million in venture financings which represents 59% of the total venture capital invested this reporting period. The largest private venture financing in California this period was into Verus Pharmaceuticals. Verus Pharmaceuticals raised $78 million and is a San Diego based pediatric-oriented pharmaceutical company identifying, developing and delivering solutions for pediatric asthma and allergies. |
|
|
 |
The biotechnology sector raised 39% of the venture capital this period. Six biotechnology companies raised $215.8 million in venture financing. The largest private venture financing in the biotechnology sector this period was into Verus Pharmaceuticals. |
|
|
 |
Companies raising their Series A round of financing led this week’s venture capital activity. Series A financings represented 40% of the total venture capital deployed this period. The largest private venture financing in Series A stage financing this period was into Eos Airlines, a Purchase, New York based airline that offers high-end, business-class only service between New York and London. |
|
|
 |
|
The three largest venture deals this period are as follows: |
| |
Company |
Industry |
Investment |
| 1 |
Eos Airlines |
Airlines |
$85 million |
| 2 |
Verus Pharmaceuticals |
Biotechnology |
$78 million |
| 3 |
Somaxon Pharmaceuticals |
Biotechnology |
$65 million |
|
 |
|
The following twelve and other unnamed investors funded the above mentioned top three venture capital investments for $228 Million: |
| 1 | Athenian Venture Partners | | 2 | BA Venture Partners | | 3 | CDIB Bioscience Ventures | | 4 | Domain Associates | | 5 | Golden Gate Capital | | 6 | Maveron | | 7 | Montreux Equity Partners | | 8 | MPM Capital Partners | | 9 | Paul Royalty Fund | | 10 | Prospect Ventures | | 11 | Sutter Hill Ventures | | 12 | Windamere Venture Partners |
|
A total of 75 equity financings of private and public companies occurred during this reporting period. Each of the 75 equity financings are profiled in a weekly report which include venture financings, private placements, secondary offerings, PIPE’s, and IPO’s.
About CapitalHunter.com
CapitalHunter.com is a web-based financial information company that identifies, preserves and electronically disseminates worldwide data on venture capital and other equity financings. Customers utilize the CapitalHunter.com searchable database to research newly and historic financings and to identify active investors.
Please visit www.capitalhunter.com and get immediate access. New subscribers can request a free investor analysis. |
|
|
|
©2003 Capital Hunter, Inc. all rights reserved
|
To be REMOVED from this free service, CLICK HERE |
